106 related articles for article (PubMed ID: 7933033)
1. Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen.
Tepper R; Cohen I; Altaras M; Shapira J; Cordoba M; Dror Y; Beyth Y
J Ultrasound Med; 1994 Aug; 13(8):635-40. PubMed ID: 7933033
[TBL] [Abstract][Full Text] [Related]
2. The role of ultrasound in the detection of endometrial pathologies in asymptomatic postmenopausal breast cancer patients with tamoxifen treatment.
Cohen I; Beyth Y; Tepper R
Obstet Gynecol Surv; 1998 Jul; 53(7):429-38. PubMed ID: 9662729
[TBL] [Abstract][Full Text] [Related]
3. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
[TBL] [Abstract][Full Text] [Related]
4. Limitations of transvaginal sonography and color Doppler imaging in the differentiation of endometrial carcinoma from benign lesions.
Chan FY; Chau MT; Pun TC; Lam C; Ngan HY; Leong L; Wong RL
J Ultrasound Med; 1994 Aug; 13(8):623-8. PubMed ID: 7933031
[TBL] [Abstract][Full Text] [Related]
5. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.
Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM
J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
[TBL] [Abstract][Full Text] [Related]
7. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
Hann LE; Gretz EM; Bach AM; Francis SM
AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
[TBL] [Abstract][Full Text] [Related]
8. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen.
Willén R; Lindahl B; Andolf E; Ingvar C; Liedman R; Ranstam J
Anticancer Res; 1998; 18(1B):667-76. PubMed ID: 9584050
[TBL] [Abstract][Full Text] [Related]
10. Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study.
Fong K; Causer P; Atri M; Lytwyn A; Kung R
Radiographics; 2003; 23(1):137-50; discussion 151-5. PubMed ID: 12533649
[TBL] [Abstract][Full Text] [Related]
11. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial.
Kedar RP; Bourne TH; Powles TJ; Collins WP; Ashley SE; Cosgrove DO; Campbell S
Lancet; 1994 May; 343(8909):1318-21. PubMed ID: 7910323
[TBL] [Abstract][Full Text] [Related]
13. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
[TBL] [Abstract][Full Text] [Related]
14. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
15. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
[TBL] [Abstract][Full Text] [Related]
16. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
Cecchini S; Ciatto S; Bonardi R; Mazzotta A; Grazzini G; Pacini P; Muraca MG
Gynecol Oncol; 1996 Mar; 60(3):409-11. PubMed ID: 8774648
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of the measurement of blood flow in uterine arteries and endometrial vessels in women with postmenopausal bleeding using "power" angio Doppler technique].
Englert-Golon M; Szpurek D; Moszyński R; Pawlak M; Sajdak S
Ginekol Pol; 2006 Oct; 77(10):759-63. PubMed ID: 17219807
[TBL] [Abstract][Full Text] [Related]
18. Transvaginal color and pulsed Doppler sonography of the endometrium: a possible role in reducing the number of dilatation and curettage procedures.
Aleem F; Predanic M; Calame R; Moukhtar M; Pennisi J
J Ultrasound Med; 1995 Feb; 14(2):139-45; quiz 147-8. PubMed ID: 8568960
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal tamoxifen treatment and endometrial pathology.
Cohen I; Altaras MM; Shapira J; Tepper R; Beyth Y
Obstet Gynecol Surv; 1994 Dec; 49(12):823-9. PubMed ID: 7885659
[TBL] [Abstract][Full Text] [Related]
20. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
